Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

NCT00215891 is registered in ClinicalTrials.gov with Hepatitis Resource Network as lead sponsor.

NCT NCT00215891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00215891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEG-Interferon a-2b + Ribavirin for Treatment of Chronic Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon
Lead sponsor
Hepatitis Resource Network
Phase
Phase 3
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c infection in hiv-infected persons, hiv infections